• Dent, J.A., Berkowitz, S.D., Ware, J., Kasper, C.K. & Ruggeri, Z.M. (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proceedings of the National Academy of Sciences of the United States of America, 87, 63066310.
  • Fujikawa, K., Suzuki, H., McMullen, B. & Chung, D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood, 98, 16621666.
  • Furlan, M., Robles, R. & Lämmle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood, 87, 42234234.
  • Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P. & Lämmle, B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 30973103.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B. (1998a) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. New England Journal of Medicine, 339, 15781584.
  • Furlan, M., Robles, R., Solenthaler, M. & Lämmle, B. (1998b) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood, 91, 28392846.
  • George, J.N. (2000) How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Blood, 96, 12231229.
  • Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lämmle, B. & Furlan, M. (1999) Assay of von Willebrand factor (VWF)-cleaving protease based on decreased collagen binding affinity of degraded VWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 13861389.
  • Lankford, K.V. & Hillyer, C.D. (2000) Thrombotic thrombocytopenic purpura: new insights in disease pathogenesis and therapy. Transfusion Medicine Reviews, 14, 244257.
  • Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, S.P., Sabio, H., Bouhassira, E.E., Upshaw, Jr, J.D., Ginsburg, D. & Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488494.
  • Moake, J.L., Turner, N.A., Stathopoulos, N.A., Nolasco, L.H. & Hellums, J.D. (1986) Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. Journal of Clinical Investigation, 78, 14561461.
  • Plaimauer, B., Zimmermann, K., Völkel, D., Antoine, G., Kerschbaumer, R., Jenab, P., Furlan, M., Gerritsen, H., Lämmle, B., Schwarz, H.P. & Scheiflinger, F. (2002) Cloning, expression and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood, 100, 36263632.
  • Rizvi, M.A., Vesely, S.K., George, J.N., Chandler, L., Duvall, D., Smith, J.W. & Gilcher, R.O. (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–hemolytic–uremic syndrome. Transfusion, 40, 896901.
  • Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nai, R.C. & Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. New England Journal of Medicine., 325, 393397.
  • Rock, G., Porta, C. & Bobbio-Pallavicini, E. (2000) Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica, 85, 410419.
  • Ruggeri, Z.M. (1999) Structure and function of von Willebrand factor. Thrombosis and Haemostasis, 82, 576584.
  • Soejima, K., Mimura, N., Hirashima, M., Maeda, H., Hamamoto, T., Nakagaki, T. & Nozaki, C. (2001) A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? Journal of Biochemistry (Tokyo), 130, 475480.
  • Tang, B.L. (2001) ADAMTS: a novel family of extracellular matrix proteases. International Journal of Biochemistry and Cell Biology, 33, 3344.
  • Tang, B.L. & Hong, W. (1999) ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Letters, 445, 223225.
  • Tsai, H.M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 87, 42354244.
  • Tsai, H.M. & Lian, E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 15851594.
  • Zheng, X., Chung, D., Takayama, T.K., Majerus, E.M., Sadler, J.E. & Fujikawa, K. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. Journal of Biological Chemistry, 276, 4105941063.